Introduction
Aortic stenosis is characterized by progressive valve narrowing and secondary changes in the myocardium 1 . In response to increased afterload, left ventricular hypertrophy can develop in order to maintain wall stress and cardiac function. Although this process appears to be compensatory in the early stages, pre-clinical studies have suggested cardiac performance can be preserved in the absence of hypertrophy 2, 3 . Moreover the left ventricular hypertrophic response ultimately decompensates with progressive cell death and fibrosis driving the transition to symptoms, heart failure and adverse cardiovascular events 1, 4, 5 . There is therefore considerable interest in identifying early, objective markers of this decompensation that might identify asymptomatic patients who would benefit from early valve replacement.
Electrocardiographic (ECG) strain is a well-recognized marker of left ventricular hypertrophy (LVH)
. However, the exact mechanism underlying the characteristic ST and T wave abnormalities associated with this pattern is uncertain. In this study, we hypothesized that ECGstrain is a marker of left ventricular decompensation, and investigated this association using cardiovascular magnetic resonance (CMR) to assess the degree of left ventricular hypertrophy and myocardial fibrosis, and high-sensitivity plasma cardiac troponin I (cTnI) as a marker of myocardial injury. Moreover, we aimed to reassess the adverse prognosis previously associated with the ECG-strain pattern in patients with aortic stenosis 6 .
Methods
Three cohorts were used for the study. In the Mechanism Cohort, we determined the pathophysiology underlying the ECG-strain pattern using CMR and plasma cTnI concentration in patients recruited from the Edinburgh Heart Centre. This was then independently validated in asymptomatic patients who would benefit from early valve replacement.
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The study was conducted in accordance with the Declaration of Helsinki, and approved by the local research ethics committee. Written informed consent was obtained from all participants.
Patient Populations

Mechanism Cohort
Patients with aortic stenosis (mild to severe) were recruited prospectively from the Edinburgh Heart Centre. We excluded patients with other significant valvular heart disease (moderate or severe), contraindications to CMR, cardiomyopathies (acquired or inherited), left or right bundle branch block, concurrent digoxin use, and impaired systolic function on CMR (ejection fraction <95 th centile for age and sex) 7 .
Validation Cohort
Between 2011 and 2013, patients with moderate to severe aortic stenosis undergoing CMR were prospectively recruited from the Royal Brompton Hospital, London, using similar exclusion criteria.
Outcome Cohort
Patients were initially recruited into the Scottish Aortic Stenosis and Lipid Lowering Trial, branch block, concurrent digoxin use, and impaired systolic function on CMR (e ej je ject ct ctio io on n n fr fr frac ac act ti tion o <95 th centile for age and sex) 7 .
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Electrocardiography
A standard 12-lead ECG was obtained in all participants and interpretation of the ECG was performed independently by two observers who were blinded to the clinical data and imaging findings. LVH on ECG was diagnosed based on the Romhilt-Estes point system ( 5 points) 9 and ECG-strain was defined as 1 mm concave downsloping ST depression with asymmetrical T wave inversion in the lateral leads ( Figure 1A ) 10 .
Echocardiography
Transthoracic echocardiography was performed in all participants in the Mechanism and Outcome Cohorts. Maximum aortic valve jet velocity and mean pressure gradient were measured by velocity time integral spectral tracing, and the aortic valve area derived using the continuity equation. Multiple acoustic windows with the S51 and D2cwc probes (Philips Medical Systems, the Netherlands) were assessed. The severity of aortic stenosis was classified according to the European Association of Echocardiography/American Society of Echocardiography guidelines 11 .
Trans-mitral early (E) and late (A) diastolic velocities and deceleration time (DT) of early filling velocity were measured at the tips of the mitral valve leaflets using pulse-wave Doppler. Early (e') diastolic velocities of the medial and lateral mitral annulus were measured using pulse-wave tissue Doppler imaging. Diastolic function was determined using the E/A ratio, DT, the mean of medial and lateral e', and E/e'. Mid-wall fractional shortening was estimated as an assessment of intrinsic myocardial contractility in the context of left ventricular hypertrophy 12 .
Cardiovascular Magnetic Resonance
CMR in the Mechanism Cohort was performed at 3T (MAGNETOM Verio, Siemens AG, Healthcare Sector, Erlangen, Germany). In the Validation Cohort, CMR was performed at 1.5T
as previously described 13 . For the assessment of left ventricular function and mass, short-axis by velocity time integral spectral tracing, and the aortic valve area derived using g t the e e co co ont nt ntin in inui ui u ty ty equation. Multiple acoustic windows with the S51 and D2cwc probes (Philips Medical Systems, h he e Ne Ne Neth th ther r rla la lan n nds) ) w w wer e e assessed. The severity of f ao ao a r rt tic stenosis wa wa as s cl las as ss si sified according to the E Eur ro ropean Ass soc oci iat t tion on o of f f Ec Ec E ho ho hoca card rd dio io iogr gra ap phy/A /A /Amer r ric c can n S So Soci ci iet t ty y o of E E Ech cho o oca ar ardi di dio og gra raph ph phy y y gu gu uid d del elin in ne es s 11 Tr Tran an ans-s-mi mi mitr tr tral al al e ear ar rl ly ly ( ( (E) E) E) a an nd nd lat at te e e (A (A (A) ) ) d di dias as sto o oli li lic c c ve e elo lo l c c citi ti ies es a and nd nd d d dec ec cel el e e e era a ati ti tion on n t tim im i e e e (D (D (DT) T) T) o o of f ea ea earl l ly y y fi fi fillin in ing g velocity wer r re e e me me meas as asur ur ured ed ed a at t th th the e e ti ti ips ps ps o o of f f th h he e e mi mi mitr tr tral al al v v val al alve ve ve lea ea eafl fl flet et ets s s us us usin in i g g g pu pu puls ls se-e-e-wa wa w ve ve ve D D Dop op oppl pl p er. Early 6 cine images from the mitral valve annulus to the apex were obtained using a balanced steadystate free precession sequence (8-mm parallel slices with 2-mm spacing). The quantification of left ventricular function, volumes and mass was assessed using dedicated software (Siemens AG Healthcare Sector, Erlangen, Germany), and indexed to body surface area. LVH on CMR was defined as a left ventricular mass index (LVMi) >95 th centile using age and sex-specific normal ranges (7) . Left ventricular longitudinal shortening was determined by measuring the difference in mitral annular displacement between end-systole and end-diastole. The mean value of the lateral and septal insertion sites (4-chamber view) and the anterior and inferior sites (2-chamber view) was used.
The assessment of focal replacement myocardial fibrosis was performed using LGE imaging, 15 min following 0.1 mmol/kg of gadobutrol (Gadovist/Gadavist, Bayer Pharma AG, Germany). Two approaches were used: an inversion recovery fast gradient-echo sequence and a phase-sensitive inversion recovery sequence, performed in two phase-encoding directions to differentiate true late enhancement from artifact. The inversion time was optimized to achieve satisfactory nulling of the myocardium. Mid-wall LGE was determined visually by two independent operators who were blinded to the ECG findings. The amount of LGE was quantified with QMASS software (Medis Medical Imaging Systems, Leiden, the Netherlands) using a signal intensity threshold greater than twice the standard deviation above the mean value in a normal region of myocardium sampled on the same short-axis image. Areas that were thought to represent inversion artifact or contamination by blood pool or epicardial fat were manually excluded.
Myocardial extracellular volume fraction (ECV) has been demonstrated to act as a measure of diffuse myocardial fibrosis in a variety of cardiac conditions, including aortic
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Long-term Follow-up in the Outcome Cohort
Clinical outcomes were obtained in the Outcome Cohort and adjudicated by two independent investigators blinded to the clinical and ECG data. In-hospital and community deaths were captured from the General Register of Scotland. Cardiovascular death was defined as death due to myocardial infarction, sudden cardiac death, heart failure, stroke, death related to cardiovascular procedures, and death due to other cardiovascular causes. Each death was classified by the two independent investigators and any discrepancy was resolved by consensus.
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Statistical Analysis
Mechanism Cohort
In the Mechanism Cohort, the association between ECG-strain and left ventricular mass and aortic stenosis severity was assessed using multivariable linear regression analysis to adjust for potential confounders. Furthermore, we assessed determinants associated with ECG-strain using univariate and multivariable logistic regression.
Outcome Cohort
In the Outcome Cohort, time-to-event curves in patients with and without ECG-strain were estimated using the Kaplan-Meier method and compared using the log-rank test. To accommodate for competing risks, the association between time to AVR or cardiovascular death and ECG-strain was modeled as a composite outcome in Cox proportional hazards models. The assumption for proportional hazards was assessed using the log (-log [survival]) versus log (survival time) plots and by examining the Schoenfeld residuals.
Results
One Moreover, compared to other groups, these patients had increased end-diastolic volumes (P<0.01), worse diastolic function (P<0.001) and more severe symptoms (P<0.001; Table 1 ).
Despite similar left ventricular ejection fraction, patients with LVH and ECG-strain also had the worst longitudinal function (Figure 2 ) and mid-wall fractional shortening (Table 1) .
Interestingly, all patients with LVH and ECG-strain had focal mid-wall fibrosis (positive and negative predictive value of 100% and 86%, respectively; Figure 3B ), strongly supporting ECG-strain as a specific marker of replacement myocardial fibrosis. Moreover these patients had more extensive diffuse myocardial fibrosis (ECV 30.9±1.9 versus 27.2±2.9 in patients with LVH and no ECG strain versus 27.4±2.2% in patients without LVH, P<0.001; Figure 3A ) and Figure 2D ). Three patients with ECG-strain had both an infarct and mid-wall pattern of fibrosis on LGE, and our findings remained unchanged even after their exclusion.
On univariate analysis, ECG-strain was associated with an increased LVMi, more severe aortic stenosis, increased replacement and diffuse myocardial fibrosis, and diastolic dysfunction (all P<0.01; Table 4 ).
Myocardial histology was available in two patients who underwent AVR and biopsy, supporting increased myocardial fibrosis in patients with LVH and ECG-strain (Figure 1) .
However, not all patients with myocardial LGE had a strain pattern on the ECG. Indeed, of the 32 patients with myocardial LGE, 11 patients (34%) did not have any evidence of ECG repolarization abnormalities. Interestingly, these patients had ~40% less replacement fibrosis on
LGE compared to patients who had ECG-strain (5.6 [4.3, 7.5] versus 9.5 [7.5, 14 .2] %, P=0.002) with no differences in the distribution of mid-wall LGE between these groups (P=0.78; see
Distribution of mid-wall fibrosis in the Online Supplemental Data).
Validation Cohort
In the external Validation Cohort, similar findings were demonstrated ( Table 2) . There were 11
patients with ECG-strain, of whom 10 had isolated mid-wall fibrosis and one had extensive fibrosis from a large myocardial infarct to explain the ECG changes. Conversely, 15 patients had mid-wall fibrosis but no ECG-strain. In this cohort of patients with moderate to severe aortic njury and diastolic dysfunction all dropping out of the model (Models 3 and 4 in in n Ta Ta Tabl bl ble e 4 4 4). ). ).
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Prognostic Value of ECG Strain
In the Outcome Cohort, 20 patients (14%) had LVH with strain on ECG. Consistent with the Mechanism Cohort, patients with ECG-strain had more severe aortic stenosis, increased LVMi and elevated plasma cTnI concentrations compared to those without strain ( Table 3 
Discussion
This is the first CMR study to investigate the mechanisms underlying the ECG-strain pattern in patients with aortic stenosis, demonstrating that it is a highly specific marker of mid-wall myocardial fibrosis. Moreover ECG-strain was associated with increased myocardial injury, impaired left ventricular performance and was an independent predictor of cardiovascular death he Mechanism Cohort (P=0.85). Over 10.6 years of follow-up (1,254 patient-ye ea a ars) s) ), 63 63 63 p p pat at atie ie ien nts had an AVR and 22 patients died from a cardiovascular cause out of a total of 36 deaths. ECG-13 or AVR. Our data therefore indicate that ECG-strain is a powerful biomarker of left ventricular decompensation in aortic stenosis with the ability to identify an at-risk population who may benefit from earlier valve replacement.
Currently, AVR is recommended in patients with severe aortic stenosis who have symptoms or evidence of LV decompensation with an ejection fraction <50% 23 . However, symptoms are often subjective, particularly in the elderly, whilst a reduced ejection fraction is frequently a late manifestation and not necessarily reversible. There is therefore interest in exploring alternative, earlier and more objective markers of ventricular decompensation in aortic stenosis 5 .
Previous echocardiographic studies have demonstrated that ECG-strain is associated with an advanced hypertrophic response 24 and it has been hypothesized that the characteristic repolarization abnormalities relate to coronary perfusion abnormalities, even in the absence of coronary artery disease [25] [26] [27] [28] . Our study adds to these data, demonstrating a close association between ECG-strain and myocardial injury and fibrosis. Indeed, across two independent cohorts, mid-wall myocardial fibrosis was present in 31 of the 32 patients with strain on their ECGs, while the remaining subject had an extensive infarct to explain the ECG changes. Moreover, patients with strain had evidence of higher plasma cTnI concentrations and worse myocardial function. It has been established that myocardial ischemia, cell death and fibrosis are all key features that characterize the transition from hypertrophy to heart failure in aortic stenosis. Our study would therefore support ECG-strain as a useful marker of left ventricular decompensation in patients with this condition.
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There are clear potential advantages of using ECG-strain as a marker of LV decompensation in aortic stenosis. A 12-lead ECG is readily available, cheap and rapidly interpretable. However, whilst ECG-strain is an extremely specific marker for myocardial fibrosis, it is less sensitive. Indeed, in our Mechanism Cohort, more than 30% of patients with replacement myocardial fibrosis did not have strain on the ECG. Importantly these patients had 40% less replacement fibrosis compared to those with strain, suggesting that strain is a relatively late manifestation and that CMR offers even more sensitive detection of myocardial fibrosis and LV decompensation.
Our data suggest that patients with ECG-strain who are asymptomatic would derive longterm benefit from early AVR, due to the prevention of progressive myocardial fibrosis and injury that would otherwise develop whilst waiting for the onset of symptoms. The stage is now set for randomized controlled studies to investigate this strategy, examining the clinical utility of the ECG-strain pattern in guiding early AVR alongside other novel and more sensitive markers of LV decompensation including high-sensitivity cTnI concentrations 20 and mid-wall LGE 13 .
Limitations
In this study, separate cohorts were used to investigate the mechanism and prognosis of patients with ECG-strain because CMR was not available in the original SALTIRE study. We therefore cannot directly confirm that ECG-strain was similarly related to myocardial fibrosis in the eplacement myocardial fibrosis did not have strain on the ECG. Importantly thes es se pa pa p ti ti tien n ents ts ts h h had ad 40% less replacement fibrosis compared to those with strain, suggesting that strain is a relatively a ate te e m m ma an anif if ifes es esta ta tation on n a and n that CMR offers even mo o ore re r s sensitive detec cti t t on n o o of f f my m ocardial fibrosis and L LV d decompens nsat at tio o on. n Ou Our r r da d data ta su ug ugge ge gest st t t tha hat t t pa pa pati ti tien en ent ts ts w w wit it th h h EC EC ECG-G-G s s str ra ain n n w w who ho ho a are re re a a asy sy ymp mp m t t tom ma mati ti tic c wo wo w ul ul uld d ECG-strain and mid-wall LGE was also observed. We are therefore confident that ECG-strain acts as a specific marker of mid-wall myocardial fibrosis and left ventricular decompensation in the predominantly Caucasian patients investigated in this study, although further studies will be required for confirmation in different ethnic groups.
Conclusions
In patients with aortic stenosis, ECG-strain is a specific marker of mid-wall myocardial fibrosis
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DISTRIBUTION OF MID-WALL FIBROSIS
Mid-wall fibrosis was predominantly found in the basal and mid-cavity (92% and 100% of all segments with late gadolinium enhancement in patients with and without ECG strain, respectively). Whilst late gadolinium enhancement was observed more commonly in the septum, inferior and inferolateral than anterior segments, the distribution was not different between those with and without ECG-strain (P=0.78).
FIGURE S1
UNADJUSTED AND ADJUSTED COX MODELS PREDICTING TIME TO
ADVERSE EVENTS
Further analyses were performed to determine the prognostic value of electrocardiographic strain in patients with aortic stenosis, adjusting for traditional markers of adverse outcomes ( Figure S2 ).
FIGURE S2
Values presented are hazard ratios for the presence of LVH strain in predicting time to aortic valve replacement or cardiovascular death 
